- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04115605
A 3 Years Naturalistic Cohort Survey of Altis Single Incision Sling System For Female Stress Urinary Incontinence
March 11, 2022 updated by: Coloplast A/S
A 3 Years Naturalistic Cohort Survey of Altis Single Incision Sling System For Female Stress Urinary Incontinence A Post-marketing and Multicenter Prospective Observational Cohort Study in Subjects With Female Stress Urinary Incontinence
The purpose of this study is to monitor the use of Altis Single Incision Sling (SIS) in a real world population and collect medical data on effectiveness and to monitor safety of Altis SIS at 12 and 36 months post device implantation in women with stress urinary incontinence.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
This project has been launched after the introduction of Altis in Europe.
This study is a multicenter prospective, observational (i.e.
naturalistic) post-marketing clinical follow-up of women for who stress urinary incontinence was diagnosed and will be treated with Altis Single Incision Sling System.
Therefore these patients will be asked to allow to use their clinical data and answer some questionnaires.
The patients'data will be collected in routine clinical practice before, during and after surgery until 12 months.
Then, questionnaires will be mailed to the participants annually during 2 additional years.
Study Type
Observational
Enrollment (Actual)
599
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Leuven, Belgium, 3000
- UZ Leuven
-
-
-
-
-
Angers, France, 49933
- CHRU Hôtel Dieu
-
Avignon, France, 84082
- Clinique Rhône Durance
-
Bordeaux, France, 33076
- CHU Pellegrin-Urology Departement
-
Bordeaux, France, 33076
- CHU Pellegrin_Gyneacology Departement
-
Bruges, France, 33523
- Polyclinique Jean Villars
-
Béziers, France, 34535
- Clinique Champeau Mediterranée
-
Castres, France, 81108
- Hôpital du Pays d'Autan
-
Chambray-lès-Tours, France, 37170
- Pole Sante Leonard de Vinci
-
Clermont-Ferrand, France, 63003
- CHU Clermont Ferrand
-
Dreux, France, 28102
- Hopital Victor Jousselin
-
Issoire, France, 63503
- CH Paul Ardier
-
La Roche sur Yon, France, 85106
- Clinique Saint-Charles
-
La Rochelle, France, 17019
- Centre hospitalier Saint Louis
-
La Rochelle, France, 17087
- Clinique du Mail La Rochelle
-
Lambres lez douai, France, 59552
- Clinique Saint-Amé
-
Libourne, France, 33500
- Ch Libourne
-
Lorient, France, 56100
- Clinique Mutualiste de la Porte de l'Orient
-
Massy, France, 91349
- Hôpital privé Jacques Cartier
-
Nogent-sur-Marne, France, 94130
- Armand Brillart Hospital
-
Poissy, France, 78303
- Chi Poissy Saint Germain En Laye
-
Rouen, France, 76044
- Clinique St Hilaire
-
Soyaux, France, 16800
- Centre Clinical
-
Toulouse, France, 31082
- Clinique Ambroise Pare
-
Toulouse, France, 31077
- Clinique Saint Jean Languedoc
-
-
-
-
-
Gunzenhausen, Germany, 91710
- Frauenärzte im Seenland
-
Memmingen, Germany, 87700
- Klinikum Memmingen
-
Worms, Germany, 67550
- Klinikum Worms gGmbH
-
-
-
-
-
Aosta, Italy, 11100
- Azienda USL Valle d'Aosta
-
-
-
-
-
Barcelona, Spain, 08035
- Hospital Vall d'Hebron
-
Tarragona, Spain, 43005
- Hospital Univeritario Joan XXIII
-
Valencia, Spain, 46026
- Hospital La Fe
-
Valladolid, Spain, 47003
- Hosital Clinico de Valladolid
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Female implanted with Altis Single Incision Sling System to treat stress urinary incontinence
Description
Inclusion Criteria:
- Implanted with Altis Single Incision Sling System
Exclusion Criteria:
- Refuses to be included in the survey or that their medical data will be used for research purposes
- Indication for Altis Single Incision Sling System implantation is not for the treatment of female urinary incontinence.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient Global Impression of Improvement (PGI-I)
Time Frame: 12 months
|
PGI-I is a validated question that collects the patient's impression of improvement after the surgery.
Among this 7 point-scale (very much better, much better, a little better, no change, a little worse, much worse and very much worse), the patients are asked to check the one number that describes how their urinay tract condition is now, compared with how it's was before the surgery.
Patients who score little or much or very much better without serious or severe related adverse events will be considered a treatment success.
The percentage of patients who describe the treatment success is measured
|
12 months
|
Adverse events
Time Frame: 12 months
|
Adverse events are any toward medical occurrence, unintended disease or injury or any untoward clinical signs in subjects.
Adverse events will be categorized according to relatedness to device or procedure, severity and frequency.
At 12-months, The percentage of patients without any device related severe or serious adverse events is measured.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cough stress test (CST)
Time Frame: Baseline, 8 weeks and 12 months
|
CST provides the means for documenting stress urinary incontinence.
CST is considered "positive" if any leakage is noted with cough or valsava.
The percentage of patients with positive and negative test will be calculated at baseline, at the post-operative visit and at one year
|
Baseline, 8 weeks and 12 months
|
Post-void residual (PVR) volume
Time Frame: Baseline, 8 weeks and 12 months
|
PVR volume will be collected pre- and post implant procedure up to 12 months.
If the PVR volume is considered normal by the physician after the procedure it is not necessary to collect these data at the subsequent follow-up visits.
|
Baseline, 8 weeks and 12 months
|
Pad Use
Time Frame: Baseline, 8 weeks, 12, 24 and 36 months
|
The number of pads used will be collected.
Patients will be considered to be pad free if they report never wearing pads or wear pads just for a sense of security.
|
Baseline, 8 weeks, 12, 24 and 36 months
|
International Consultation on Incontinence Questionnaire (ICIQ-UI)
Time Frame: Baseline, 8 weeks, 12, 24 and 36 months
|
The ICIQ-UI Short Form is a seft-administred questionnaire to evaluate the frequency, severity and impact on quality of life of urinary incontinence.
Question 1 asked, "How often do you leak urine?"
Subjects were instructed to select among "none" (0), "about once a week or less often" (1), "2 or 3 times a week" (2), "about once a day" (3), "several times a day" (4), and "all the time" (5).
Question 2 asked, "How much urine do you usually leak (whether you wear protection or not)?" Patients responded with "none" (0), "a small amount" (2), "a moderate amount" (4) or "a large amount (6).
Question 3 asked, "Overall, how much does leaking urine interfere with your everyday life?" Participants chose a number from 0 (not at all) to 10 (a great deal).
Question 1, 2 and 3 are summed to compute the total ICIQ score.The total score range is then a minimum of 0 to a maximum of 21.
The mean score, aboslute and relative change compared to baseline will be measure
|
Baseline, 8 weeks, 12, 24 and 36 months
|
Subject global satisfaction questionnaire
Time Frame: 8 weeks, 12, 24, 36 months
|
This non-validated questionnaire provides additional information concerning patient satisfaction.
This survey consists of two questions: Question 1 "how satisfied are you with your surgery?".
Among 5 point-scale (very satisfied, satisfied, not satisfied-not dissatisfied, dissatisfied and very dissatified), patient check the one items that best describes the subject satisfaction.
We measure the percentage the patients who very satisfied and satisfied.
The patients answer the question "Do you recommend this operation to a friend?" by "yes" or "no".
We measure the percentage of patients who answer "yes".
|
8 weeks, 12, 24, 36 months
|
Incontinence quality of life questionnaire (I-QoL)
Time Frame: Baseline, 8 weeks, 12, 24, 36 months
|
The Incontinence quality of life questionnaire (I-QoL) is a validated survey questionnaire with 22 items that are scored on a 5-point Likert scale.
The I-QOL ans its subcale scores are computed by adding each item's reponse, subtracting the lowest possible score and diving that sum by the possible raw score range.
The scores are then transformed to have a range from 0 (maximum problem) to 100 (no problem at all).
The mean score, absolute and relative change compared to baseline
|
Baseline, 8 weeks, 12, 24, 36 months
|
Impact on sexual function assessed by the Pelvic organ/urinary incontinence sexual questionnaire (PISQ 12)
Time Frame: Baseline, 8 weeks, 12, 24, 36 months
|
The Pelvic organ/urinary incontinence sexual questionnaire (PISQ-12) is a validated and reliable short form questionnaire including 12 questions that evaluates sexual function in heterosexual women with urinary incontinence and/or pelvic oragn prolapse.
Reponses are graded on a 5-point Likert scale from "never" to "always".
The scores will be calculated at each assessment visit.
The mean score, absolute and relative change compared to baseline
|
Baseline, 8 weeks, 12, 24, 36 months
|
Patient Global Impression of Improvement (PGI-I)
Time Frame: 8 weeks, 24, 36 months
|
PGI-I is a validated question that collects the patient's impression of improvement after the surgery.
Among this 7 point-scale (very much better, much better, a little better, no change, a little worse, much worse and very much worse), the patients are asked to check the one number that describes how their urinay tract condition is now, compared with how it's was before the surgery.
The percentage of patients who describe very much better or much better or little better is measured
|
8 weeks, 24, 36 months
|
Adverse events
Time Frame: 8 weeks, 24, 36 months
|
Adverse events are any toward medical occurrence, unintended disease or injury or any untoward clinical signs in subjects.
Adverse events will be categorized according to relatedness to device or procedure, severity and frequency.
The percentage of patients without any device related severe or serious adverse events is measured.
|
8 weeks, 24, 36 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Grégoire Capon, MD, CHU Pellegrin, Bordeaux, France
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 27, 2015
Primary Completion (Actual)
September 22, 2021
Study Completion (Anticipated)
September 22, 2023
Study Registration Dates
First Submitted
July 23, 2015
First Submitted That Met QC Criteria
October 3, 2019
First Posted (Actual)
October 4, 2019
Study Record Updates
Last Update Posted (Actual)
March 28, 2022
Last Update Submitted That Met QC Criteria
March 11, 2022
Last Verified
March 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SU017
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Urinary Incontinence, Stress
-
University of New MexicoRecruitingUrinary Incontinence | Urge Incontinence | Stress Incontinence, FemaleUnited States
-
University of California, San FranciscoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Stanford...CompletedUrinary Incontinence, Stress | Urge Incontinence | Urinary Stress Incontinence | Stress Incontinence, Urinary | Stress Incontinence | Stress Incontinence, Female | Urgency UrinaryUnited States
-
Juna d.o.o.CompletedFemale Stress Urinary Incontinence | Mixed Incontinence, Urge and Stress
-
Université de SherbrookeRecruitingUrinary Incontinence | Urinary Stress Incontinence | Post-Prostatectomy Incontinence | Stress Incontinence, MaleCanada
-
Far Eastern Memorial HospitalRecruitingWomen With Stress Urinary IncontinenceTaiwan
-
University Magna GraeciaUnknownStress Urinary IncontinenceItaly
-
Hadassah Medical OrganizationCompletedUrinary Stress Incontinence (SI)Israel
-
University of California, IrvineWithdrawnStress Urinary IncontinenceUnited States
-
Eli Lilly and CompanyBoehringer IngelheimCompleted
-
Eli Lilly and CompanyBoehringer IngelheimCompletedUrinary Stress IncontinenceUnited States
Clinical Trials on Altis Single Incision Sling
-
Coloplast A/SCompletedStress Urinary IncontinenceSpain, France, Italy, Germany, Netherlands
-
Coloplast A/SCompletedStress Urinary IncontinenceUnited States, Canada
-
Coloplast A/SCompletedStress Urinary IncontinenceUnited States, Canada
-
Michigan Institution of Women's Health PCActive, not recruitingStress Urinary IncontinenceUnited States
-
Maltepe UniversityCompletedStress Urinary IncontinenceTurkey
-
C. R. BardCompletedFemale Stress Urinary IncontinenceUnited States
-
Boston Scientific CorporationCompletedStress Urinary IncontinenceUnited States, Australia
-
American Medical SystemsUnknownStress Urinary Incontinence in WomenUnited States
-
The Christ HospitalCompletedStress Incontinence, FemaleUnited States